List of figure legends
Figure 1. First cervical cytology: squamous cell carcinoma (×40 Pap
smear).
Figure 2. Pathological specimen from conization: carcinoma in situ (×20
hematoxylin and eosin stain).
Figure 3. Cervical cytology 4 months after the second allogenic stem
cell transplantation: high-grade squamous intraepithelial lesion (×40
Pap smear).
Figure 4. Cervical cytology 11 months after the second allogenic stem
cell transplantation: atypical squamous cells of undetermined
significance (×40 Pap smear).
Figure 5. Cervical cytology 16 months after the second allogenic stem
cell transplantation: negative for intraepithelial lesion or malignancy
(×40 Pap smear).
Figure 6. Pathological specimen from hysterectomy: cervical
intraepithelial neoplasia, grade 3/HSIL (×20 hematoxylin and eosin
stain).
Figure 7. Cervical cytology 2 months after hysterectomy: squamous cell
carcinoma (×40 Pap smear).
Figure 8. Cervical cytology 5 months later after hysterectomy:
high-grade squamous intraepithelial lesion (×40 Pap stain).
Figure 9. Cervical cytology 3 years after hysterectomy: negative for
intraepithelial lesion or malignancy (×40 Pap stain).
Figure 10. Course of cervical cytology and dose of immunosuppressant.
ASC-H, atypical squamous cells cannot exclude HSIL; ASC-US, atypical
squamous cells of undetermined significance; ATH+BSO, abdominal total
hysterectomy and bilateral salpingo-oophorectomy; HSIL, high-grade
squamous intraepithelial lesion; NILM, negative for intraepithelial
lesion or malignancy; SCC, squamous cell carcinoma.